Lukas Perkhofer

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Cancers

Gut

Vaccines

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Jens Ettrich, Dominik Paul Modest, Marianne Sinn, Jana K Striefler, Bernhard Opitz, Thorsten Goetze, Eike Gallmeier, Stefan Angermeier, Ludwig Fischer von Weikersthal, Lutz Jacobasch, Dirk Waldschmidt, Michael Niedermeier, Michael Sohm, Andreas W Berger, Giulia Manzini, Uli Fehrenbach, Timo Alexander Auer, Clarissa Hosse, Daniel Vogele, Disorn Sookthai, Marina Schaaf, Rainer Muche, Axel Hinke, Thomas Seufferlein, Lukas Perkhofer
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Viktoria Hentschel, Cornelia Horsch, Benjamin Mayer, Annsophie Thies, Will Qian, Joris Kroschel, Thomas Seufferlein, Lukas Perkhofer, Martin Müller
A Systematic Evaluation of the SARS-CoV-2 Vaccine-Induced Anti-S-RBD-Ig Response in a Population of Health Care Workers. Vaccines 11 (9) (2023)
Niklas Sturm, Jasmin Selina Schuhbaur, Felix J Hüttner, Lukas Perkhofer, Thomas Jens Ettrich
Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions. Cancers 14 (22) (2022)
Niklas Sturm, Thomas Jens Ettrich, Lukas Perkhofer
The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. Cancers 14 (1) (2022)
Jessica Merkle, Markus Breunig, Maximilian Schmid, Chantal Allgöwer, Jana Krüger, Michael Karl Melzer, Susanne Bens, Reiner Siebert, Lukas Perkhofer, Ninel Azoitei, Thomas Seufferlein, Sandra Heller, Matthias Meier, Martin Müller, Alexander Kleger, Meike Hohwieler
CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome. Cancers 13 (20) (2021)
Johanna Backhus, Christian Neumann, Lukas Perkhofer, Lucas A Schulte, Benjamin Mayer, Thomas Seufferlein, Martin Müller, Alexander Kleger
A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab. Journal of clinical medicine 10 (6) (2021)
Alica K Beutel, Lena Schütte, Jeanette Scheible, Elodie Roger, Martin Müller, Lukas Perkhofer, Annika M T U Kestler, Johann M Kraus, Hans Armin Kestler, Thomas F E Barth, Johannes Lemke, Marko Kornmann, Thomas Jens Ettrich, Johann Gout, Thomas Seufferlein, Alexander Kleger
A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Cancers 13 (11) (2021)
Lukas Perkhofer, Talia Golan, Pieter-Jan Cuyle, Tamara Matysiak-Budnik, Jean-Luc Van Laethem, Teresa Macarulla, Estelle Cauchin, Alexander Kleger, Alica K Beutel, Johann Gout, Albrecht Stenzinger, Eric Van Cutsem, Joaquim Bellmunt, Pascal Hammel, Eileen M O'Reilly, Thomas Seufferlein
Targeting DNA Damage Repair Mechanisms in Pancreas Cancer. Cancers 13 (17) (2021)
Johann Gout, Lukas Perkhofer, Mareen Morawe, Frank Arnold, Michaela Ihle, Stephanie Biber, Sebastian Lange, Elodie Roger, Johann M Kraus, Katja Stifter, Stephan A Hahn, Andrea Zamperone, Thomas Engleitner, Martin Müller, Karolin Walter, Eva Rodriguez-Aznar, Bruno Sainz, Patrick C Hermann, Elisabeth Hessmann, Sebastian Müller, Ninel Azoitei, André Lechel, Stefan Liebau, Martin Wagner, Diane M Simeone, Hans A Kestler, Thomas Seufferlein, Lisa Wiesmüller, Roland Rad, Pierre-Olivier Frappart, Alexander Kleger
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. Gut 70 (4) (2020)
Lukas Perkhofer, Johann Gout, Elodie Roger, Fernando Kude de Almeida, Carolina Baptista Simões, Lisa Wiesmüller, Thomas Seufferlein, Alexander Kleger
DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives. Gut 70 (3) (2020)

Lukas Perkhofer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lukas Perkhofer